News Announcement

Morepen Laboratories: Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release with the title Morepen Labs adds three new drugs - Rivaroxaban Vildagliptin and UDCA to its API portfolio.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.